Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Prostatic Neoplasms, Castration-Resistant 2Seizures 1Prostate Cancer Metastatic 1Primary Dysautonomias 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Kidney Diseases 1Hypertension 1Dementia 1Cognitive Dysfunction 1

Interventions

enzalutamide 1Prednisolone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Metastatic Castration-Resistant Prostate Cancer × enzalutamide × Clear all
NCT02116582 2024-12-06

A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Astellas Pharma Inc

Phase 4 Completed
215 enrolled 11 charts
Genitourinary

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡